EGFR and small cell lung carcinoma: The loss of sensitivity to EGFR TKIs following SCLC transformation seems to be mediated partly by the downregulation of the expression of EGFR protein, although alterations in EGFR-dependent and EGFR-independent pathways might also contribute [52].